Skip to main content

Table 5 Proportion of T-lymphocyte subsets of mice treated with DT18.

From: Antiangiogenic and Antitumoral Effects Mediated by a Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1)-Targeted DNAzyme

 

CD3+ (%)

CD4+ (%)

CD8+ (%)

Saline

6.50 ± 1.35

8.02 ± 0.98

2.78 ± 0.56

INV-Ctrl

6.91 ± 1.46

8.95 ± 1.15

3.03 ± 0.42

DT18

7.19 ± 1.68

8.95 ± 1.09

3.19 ± 0.27

F value

0.620

3.120

1.718

P value

0.733

0.210

0.424

  1. Data were analyzed by one-way ANOVA followed by the Dunnett test. The DT18 group was compared with the saline group and INV-Ctrl group (n = 5).
Back to article page

Molecular Medicine

ISSN: 1528-3658